STUDY OF PROTECTIVE EFFECTS OF 5,6,7,8-TETRA-HYDRONEOPTERIN AGAINST X-RAY RADIATION INJURY

5,6,7,8-四氢蝶呤对X射线辐射损伤的防护作用研究

• 批准号: 08671504
• 负责人: MORIMOTO Takeshi
• 金额: $ 1.22万
• 依托单位: AICHI CANCER CENTER RESEARCH INSTITUTE
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (C)
• 财政年份: 1996
• 资助国家: 日本
• 起止时间: 1996 至 1997
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-08671504/
• 关键词: NEOPTERIN; PTERIDINE; X-RAY; T CELL; B CELL; RADIATION INJURY; MOUSE; PROTECTION; ネオプテリン; X線; 放射線障害抑制

The protective effects of 5,6,7,8-tetrahydroneopterin (NPH-4) against radiation injury in mice was studied. (C57BL/6 x A/J) F1 (B6A) mice of received a single whole-body irradiation dose of 200,400,700 or 800 cGy X-rays. NPH-4 (30mg/kg body weight) or BPS were injected intraperitoneally into irradiated mice 10 minutes before and after the irradiation and again after 6 hours. All mice which received the 800 cGy radiation + PBS died between 8 to 11 days after the treatment. In contrast, those that also received NPH-4 demonstrated a significantly prolonged survival time and 40% lived more than 5 months. Total numbers of thymocytes and spleen cells on day 5 post-irradiation were dramatically reduced in line with the radiation dose. The survival was significantly enhanced by in NPH-4 treated. Proliferation of spleen cells in mice stimulated by concanavilin A (Con A) or lipopolysaccharide (LPS) was also greater in NPH-4 treated mice. The immune response of survivors, 5 months after 800 cGy + NPH-4 treatments, against Con A,LPS,allogeneic mouse, and seep red blood cells (SRBC) had essentially ecovered to the levels of normal mice. These results indicate that NPH-4 had an important role in preventing radiation injury.In conclusion, NPH-4 may be useful as a therapeutic agent against diseases in which active oxygen species act as potent pathogenic factors, such as with post-radiation injury. In particular, NPH-4 might findapplication in combination with radiation therapy for human cancers with poor blood vessel formation such as some pancreatic carcinomas.

研究了5，6，7，8-四氢新蝶呤（NPH-4）对小鼠辐射损伤的保护作用。（C57 BL/6 x A/J）F1（B6 A）小鼠接受200、400、700或800 cGy X射线的单次全身照射剂量。照射前、后10分钟及照射后6小时分别腹腔注射NPH-4（30 mg/kg体重）或BPS。所有接受800 cGy辐射+ PBS的小鼠在治疗后8至11天死亡。相比之下，那些也接受NPH-4的患者的生存时间显着延长，40%的患者存活超过5个月。照射后第5天，胸腺细胞和脾细胞的总数急剧减少，与辐射剂量一致。在NPH-4处理中，存活率显著提高。在NPH-4处理的小鼠中，伴刀豆球蛋白A（Con A）或脂多糖（LPS）刺激的小鼠中的脾细胞增殖也更大。800 cGy + NPH-4治疗5个月后，存活小鼠对ConA、LPS、同种异体小鼠和渗漏红细胞（SRBC）的免疫应答基本恢复到正常小鼠水平。这些结果表明，NPH-4在预防辐射损伤中具有重要作用。总之，NPH-4可能用作治疗剂，用于治疗以活性氧作为潜在致病因素的疾病，例如辐射后损伤。特别是，NPH-4可能与放射疗法联合应用于血管形成不良的人类癌症，如某些胰腺癌。

项目成果

Takeuchi, M.et al.: "Suppression of sponatneous uveoretinitis development by non-immunopathogenic peptide immunization." European Journal of Immunology. (in press). (1998)

Takeuchi, M.等人：“通过非免疫致病性肽免疫抑制自发性葡萄膜视网膜炎的发展。”

Ohno,K. et al.: "Successful transfer of localized autoimunity with positively selected CD4+ cells to scid mice locking functional B cells." Autoimmunity. (in press).

大野，K.

Taguchi,O.,& Takahashi,T.: "Administration of anti-intreleukin-2 receptor alpha antibody in vivo induces localized autoimmune disease." Eur.J.Immunol.26. 1608-1612 (1996)

田口，O.，

Kezuka, T., Sakai, J., Yokoi, H., Takeuchi, M., Okada, A., Taguchi, O., Usui, M.& Mizuguchi, J.: "Peptide-mediated suppression of expermental autoimmune uveoretinitis (EAU) in mice : development of a peptide vaccine" Int.Immunol. 18. 1229-1235 (1996)

Kezuka，T.，Sakai，J.，横井，H.，竹内，M.，冈田，A.，田口，O.，臼井，M.

Doi,T. et al.: "NF-κ B relA deficient lymphocytes: Normal development of T cells and B cells,impaired production of lgA and lgGl and reduced proliferative responses." Journal of Experimental Medicine. 185. 953-961 (1997)

Doi, T. 等人：“NF-κ B relA 缺陷淋巴细胞：T 细胞和 B 细胞的正常发育，IgA 和 IgGl 的产生受损以及增殖反应减少。”实验医学杂志 185. 953-961 (1997) ）